Open Access

Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress

  • Simone Mori1,
  • Shuei Sugama2,
  • William Nguyen1,
  • Tatiana Michel1, 3,
  • M. Germana Sanna1,
  • Manuel Sanchez-Alavez4,
  • Rigo Cintron-Colon1,
  • Gianluca Moroncini5,
  • Yoshihiko Kakinuma2,
  • Pamela Maher6 and
  • Bruno Conti1, 4, 7Email authorView ORCID ID profile
Journal of Neuroinflammation201714:88

DOI: 10.1186/s12974-017-0862-1

Received: 17 November 2016

Accepted: 7 April 2017

Published: 21 April 2017

Abstract

Background

The majority of Parkinson’s disease (PD) cases are sporadic and idiopathic suggesting that this neurodegenerative disorder is the result of both environmental and genetic factors. Stress and neuroinflammation are among the factors being investigated for their possible contributions to PD. Experiments in rodents showed that severe chronic stress can reduce the number of dopaminergic neurons in the substantia nigra pars compacta (SNc); the same cells that are lost in PD. These actions are at least in part mediated by increased oxidative stress. Here, we tested the hypothesis that the interleukin-13 receptor alpha 1 (IL-13Rα1), a cytokine receptor whose activation increases the vulnerability of dopaminergic neurons to oxidative damage, participates in the stress-dependent damage of these neurons.

Methods

Mice were subject to daily sessions of 8 h (acute) stress for 16 weeks (5 days a week), a procedure previously showed to induce loss of dopaminergic neurons in the SNc. The source and the kinetics of interleukin-13 (IL-13), the endogenous ligand of IL-13Rα1, were evaluated 0, 1, 3, 6, and 8 h and at 16 weeks of stress. Identification of IL-13 producing cell-type was performed by immunofluorescent and by in situ hybridization experiments. Markers of oxidative stress, microglia activation, and the number of dopaminergic neurons in IL-13Rα1 knock-out animals (Il13ra1 Y/ ) and their wild-type littermates (Il13ra1 Y/+ ) were evaluated at 16 weeks of stress and at 20 weeks, following a 4 week non-stressed period and compared to non-stressed mice.

Results

IL-13 was expressed in microglial cells within the SN and in a fraction of the tyrosine hydroxylase-positive neurons in the SNc. IL-13 levels were elevated during daily stress and peaked at 6 h. 16 weeks of chronic restraint stress significantly reduced the number of SNc dopaminergic neurons in Il13ra1 Y/+ mice. Neuronal loss at 16 weeks was significantly lower in Il13ra1 Y/− mice. However, the loss of dopaminergic neurons measured at 20 weeks, after 4 weeks of non-stress following the 16 weeks of stress, was similar in Il13ra1 Y/+ and Il13ra1 Y/− mice.

Conclusions

IL-13, a cytokine previously demonstrated to increase the susceptibility of SNc dopaminergic neurons to oxidative stress, is elevated in the SN by restraint stress. Lack of IL-13Rα1 did not prevent nor halted but delayed neuronal loss in the mouse model of chronic restraint stress. IL-13/IL-13Rα1 may represent a target to reduce the rate of DA neuronal loss that can occur during severe chronic restraint stress.

Keywords

Stress Interleukin Parkinson’s disease Neuroinflammation Microglia Oxidative stress

Background

Parkinson’s disease (PD) is the second most common neurodegenerative disorder affecting approximately 1% of the population over the age of 60 [1]. Clinical symptoms include tremors, rigidity, and postural instability which are believed to arise primarily from the progressive reduction of dopamine signaling in the basal ganglia resulting from the loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Although several genes have been demonstrated to contribute to familial PD, the majority of PD cases are sporadic and idiopathic, with environmental factors thought to contribute to the development of the disease [2]. Stressful psychological events and neuroinflammation are among the environmental factors being investigated in PD research.

The contribution of stress to neurodegeneration was studied extensively in the hippocampus where the hormone glucocorticoids were demonstrated to mediate neuronal loss [35]. Correlative and experimental evidences also suggested that stress may contribute to loss of dopaminergic neurons and thus contribute to the etiology or to the progression of PD [614]. Several studies also showed that different types of stressor including restraint, [1518], prenatal [19], dental disharmony [20], and cold stress [21], can lead to the activation of microglial-increasing reactive oxygen species (ROS) and interleukins [22] creating a neuroinflammatory environment that is believed to contribute to PD [2325].

In an effort to elucidate the possible contribution of neuroinflammation to PD and how its supposedly non-specific action could lead to a preferential loss of DA neurons, we previously showed that this is mediated, at least in part, by activation of the receptor alpha 1 of interleukin-13 (IL-13Rα1) [26]. IL-13Rα1 is known for its peripheral role of mediating allergic inflammation and atopy, but it is also expressed centrally in DA neurons of the SNc and the VTA where its activation increased cellular susceptibility to oxidative stress [26]. Interestingly, Il13ra1 is localized at position Xq24 of the human X chromosome, within a region containing the PARK 12 locus associated with PD.

Preliminary studies showed that restraint stress elevated the level of IL-13 in the CNS [27]. Here, we tested the hypothesis that activation of IL-13Rα1 contributes to the loss of DA neurons occurring in a mouse model of severe chronic restraint stress (RS) consisting of daily 8 h long RS sessions for 5 days a week for 16 weeks [11]. We determined the central cellular source of IL-13 that measured the kinetics of its production and the effects that stress had on microglial activation and oxidative damage during the daily session of 8 h RS and at 16 weeks. The number of DA neurons in the SNc in mice null for IL-13Rα1 (Il13ra1 Y/− ) and their wild-type littermates (Il13ra1 Y/+ ) was determined and compared at 16 or at 20 weeks, 4 weeks after termination of stress.

Methods

Animals and tissue harvesting

Mouse husbandry and procedures were approved and performed under the guidelines of the Institutional Animal Care and Use Committee of The Scripps Research Institute and by the Institutional Animal Care and Use Committee of Nippon Medical School and were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals; animal suffering and sacrifice were minimized. All experiments were carried out on 3–6-month-old male mice null for IL-13Rα1 (Il13ra1 Y− ) and wild-type littermates (Il13ra1 Y/+ ) on a C57BL/6 background [28]. Animals were housed in a room maintained at 20–22 °C, on a 12-h light/12-h dark with food and water provided ad libitum. For tissue collection, animals were deeply anaesthetized using 4–5% isoflurane and subsequently perfused with 0.1 M phosphate buffer for real-time PCR analysis or with 0.1 M phosphate buffer followed by 4% paraformaldehyde (PFA) for histological analysis. After overnight post-fixation in 4% PFA, the brains to be used for histological analysis were cryoprotected in 30% sucrose then frozen at −80 °C. The brains were sectioned using a Leica cryostat to produce 35 μm slices for both immunohistochemistry and immunofluorescence.

Stress experiment

Restraint stress (RS) was performed as previously described [11] on age-matched Il13ra1 Y/− and Il13ra1 Y/+ mice. Briefly, animals were placed in ventilated plexiglass restrainers that prevented the mice from turning without causing any pain for a maximum of eight consecutive hours per day. Chronic stress was achieved by performing this acute stress procedure daily for 5 days a week for a maximum of 16 weeks; a regimen previously shown by us to induce loss of DA neurons in the SNc [11] (Fig. 1a, b). Tissues were also collected at the end of the last 8-h session at 16 weeks RS or at the same time of day after 4 additional weeks after termination of stress (week 20) (Fig. 1c).
Fig. 1

Experimental restraint stress paradigms. Schematic representation of stress regimen and experimental design. a Daily sessions of 8 h RS were performed from 8 AM to 4 PM. Levels of IL-13 transcripts were determined at 1, 3, 6, and 8 h and the neuroinflammatory response. b Weekly schedule of RS consisted 8 h RS/day for 5 consecutive days per week followed by 2 days of non-stress. c Severe chronic RS consisted of the weekly RS schedule for a maximum up to was applied for 16 weeks. Distinct groups of animals were maintained in non-stressed conditions for four additional weeks following last session of stress before tissue was collected for analysis

Immunohistochemistry

Immunofluorescence microscopy was performed on 35-μm brain slices containing the region of interest (see Additional file 1: Figure S1a). The following primary antibodies were used: rabbit-anti Iba-1 (1:500, Wako); rabbit anti-GFAP (1:250, Thermo Fisher); mouse monoclonal anti-NeuN (1:250, Millipore); goat anti-IL-13 (1:50, R&D system), rabbit anti-3-Nitrotyrosine (3-NT, 1:200, Millipore). After washing, a combination of secondary antibodies was used for detection: 488 Alexa goat anti-rabbit, 594 Alexa goat anti-mouse IgG1 (Invitrogen). Slides were counterstained with DAPI and were cover-slipped in Fluoromount. Digital images were taken using a Zeiss LSM 710 laser scanning confocal microscope (LSCM). Tyrosine Hydroxylase DAB Immunohistochemical analysis was performed using rabbit anti-Tyrosine Hydroxylase, (1:10000; Millipore), incubated with a biotinylated goat-anti rabbit antibody (1:400; Vector Labs) for 1 h at RT and then stained with Vectastain ABC Kit (Standard) and DAB Peroxidase Substrate (Vector Labs). For cresyl violet (CV) staining (Nissl), adjacent sections were mounted on positive charged slides and air-dried. The slides were soaked in CV solution (0.25% cresyl violet and 0.3% acetic acid) for 15 min (warmed at 50 °C), were dehydrated with alcohol and xylene, and were cover-slipped with Vectamount.

Cell counting

Cell counting was performed by unbiased stereology. Briefly, digital images of TH- and CV-positive cells were acquired on the SNc at ×50 magnification on an Olympus microscope fitted with a video camera (Olympus, Tokyo, Japan). Counting frames (100 × 100 μm) were generated using MCID image analysis software (Imaging Research Inc., Ontario, Canada) and were systemically scanned over the outlined SNc using a motorized stage. Neurons were counted when they appeared within a square (50 × 50 μm) of the counting frame but were not in contact with the left or bottom border. This procedure was carried out on every four sections at a periodicity of 140 μm through the SNc. Finally, total SNc neuron number was calculated as the product of the neuron density and the volume of the SNc as previously reported [29, 30]. To count the number of double-positive-labeled cells (IL13-green) and (Iba-1, GFAP, NeuN, or Tyrosine Hydroxilase-red), we used region of interest analysis macros in Image Pro Premier (Media Cybernetics) [28]. Digital images were taken using a Zeiss LSM 710 laser scanning confocal microscope LSCM. A maximum intensity projection (MIP) was created of each multi-sectioned reconstruction of the double-positive-labeled cells using the Zen software. For further processing, the MIPs of each sample were imported into Image Pro Premier (Media Cybernetics) where the region of the SN was defined (outline) to create a mask of the whole region of interest. Four counting frames (100 × 100 μm) were generated using Image Pro Premier Software for each MIP image. The number of red, green, and total nuclear count (DAPI) in each frame was counted with the exclusion of those not in contact with the left or bottom border. These results were represented as number of cell/total nuclear count extracted from the total area for each fluorescent-labeled population. Double-positive populations were defined by scoring, outlined as a region of interest, all of one population (signal Red-TH), and obtaining from the software how much of the other (green-IL-13) resides within the red-positive region of interest. 3-NT fluorescence intensity arbitrary units (a.u.) were calculated by dividing the detected optical density by area of the region of interest.

Tissue processing for protein quantification and semi-quantitative PCR

Real-time PCR and IL-13 ELISA were performed on SN samples from IL-13Rα1 wild-type mice. Animals (6–7 per group) were perfused intracardially with PBS at different time points of acute RS (3, 6, and 8 h), and the SN was rapidly dissected and flash frozen. Total RNA was isolated using a RNA extraction kit (NucleoSpin RNA Plus, Macherey-Nagel #740984.250) according to the manufacturer’s protocol. After eluting the RNA product with RNase/DNase-free water, the concentration and purity of the RNA was determined using a NanoDrop ND-1000 spectrophotometer. Total RNA was reverse transcribed into cDNA using a reverse transcription cDNA synthesis kit (Maxima cDNA Synthesis Kit, Thermo Fisher, #FERK1642) per the manufacturer’s protocol. The cDNA templates were amplified via PCR using the Taq polymerase enzyme (PowerUP Sybr Master Mix, Life Technologies, #A25777) along with mouse IL-13-specific primers obtained from Qiagen RT2 qPCR Primer Assay, (PPM03021B). IL-13Rα1 primers used as follows: FW 5′-cct tgc ttc tgt ggt agt aga g-3′ and RW 5′- aaa ggg cca gga gga aat ac-3′. A Bio-Rad CFX 384 PCR System was used to perform the qPCR reactions. Data were analyzed using the ∆∆Ct method with the levels of the gene of interest normalized to the beta Actin housekeeping gene. For protein extraction, SN samples were homogenized in 400 μl of lysis buffer (N-PER™ Neuronal Protein Extraction Reagent, Thermo Fisher, plus 1 protease inhibitor cocktail tablet) and then were centrifuged at 14,000g for 30 min at 4 °C. The supernatants were collected, and protein concentrations were determined by Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, USA). Samples were analyzed in a ELISA for mouse IL-13 (R&D) according to the manufacturer’s instruction, and results normalized for total protein (pg IL-13/mg total protein).

Statistical analysis

One-factor ANOVA followed by a Bonferroni post hoc test was used to determine statistical significance (*p < 0.05, **p < 0.01; ***p < 0.001) using GraphPad Prism Software (La Jolla, CA, USA).

Results

IL-13 is increased by acute RS in the substantia nigra

IL-13Rα1 is expressed in dopaminergic neurons where its activation during neuroinflammation increases their vulnerability to oxidative stress in the SNc [26]. We previously demonstrated that repetitive sessions of acute daily of 8 h RS can eventually reduce the number of DA neurons in the SNc [11]. To determine whether the daily session of acute stress would modify the level of IL-13, we measured IL-13 mRNA, immunoreactivity, and protein level in the SN of animals restrained for 0, 1, 3, 6, or 8 h (Fig. 2). Semi-quantitative RT-PCR analysis revealed that RS elevated the IL-13 mRNA. The increase was the highest and most significant at 6 h of RS with fold change compared to non-stressed animals being 3.89 ± 1.545, n = 6, p = 0.04. Fold difference compared to control (arbitrarily assigned the value of 1) did not reach statistical significance at the other time-point tested (0.37 ± 0.032, n = 6, p > 0.99 at 1 h RS; 0.90 ± 0.186, n = 6, p > 0.99 at 3 h RS; 2.63 ± 0.704, p = 0.74 at 8 h RS) (Fig. 2a). The levels of IL-13Rα1 mRNA were also determined (Fig. 2b) with no alterations on the mRNA levels of the IL-13 receptor at all time points. ELISA demonstrated that RS also elevated the level of IL-13 protein and that such increase was statistically significant at 8 h when the fold change compared to non-stressed animals was of a similar order of magnitude as the transcript at 6 h (IL-13 in pg/mg total protein: 2.644 ± 0.50 control; 5.607 ± 2.793 at 1 h RS, NS; 7.128 ± 3.123, at 3 h, NS; 8.857 ± 1.361 at 6 h RS, NS, and 11.7 ± 3.195 at 8 h RS, p < 0.05) (Fig. 2c).
Fig. 2

Acute restraint stress induces central production of IL-13 in the substantia nigra. a Semi-quantitative RT-PCR performed on RNA extracted from the SN of mice treated with acute RS showed that compared with the level of control animals, arbitrarily fixed to 1 (n = 8), levels were 0.37 ± 0.032, p > 0.99; 0.90 ± 0.186, p > 0.99; 3.89 ± 1.545, p = 0.04 and 2.63 ± 0.704, p = 0.74 at 1, 3, 6, and 8 h, respectively, n = 6. b Semi-quantitative RT-PCR assessing expression of IL-13Rα1 on same samples described in figure A shows no difference in all time points compared to control condition (p > 0.99 at control, 1, 3, 6, and 8 h). c Protein quantification in the SN shows upregulation of IL-13 during restraint stress (IL-13 in pg/mg total protein: 2.644 ± 0.50 control; 5.607 ± 2.793 at 1 h RS, p > 0.99;7.128 ± 3.123, at 3 h, p = 0.679; 8.857 ± 1.361 at 6 h RS, p = 0.1612, and 11.7 ± 3.195 at 8 h RS, p = 0.0342)

Immunohistochemistry further confirmed that IL-13 protein expression increased at 8 h of RS and demonstrated that the cellular source of IL-13 was distributed in both the SN pars compacta (SNc) and the SN pars reticulata (SNr) (Fig. 3A–A′). Similar results were obtained when evaluating the presence and distribution of IL-13 by immunohistochemistry at 16 weeks of stress (Fig. 3A′′). These data indicate that stress paradigm used here elevated IL-13 providing evidence that the treatment used effectively led to a local increase of IL-13Rα1 ligand.
Fig. 3

Mapping the location of IL-13 production in the substantia nigra. (AA″) Representative pictures of immunofluorescent staining of IL-13 (green) in the SN of non-stressed (top), 8 h of RS (center) and after 16 weeks of RS (bottom); showing that RS elevates IL-13 expression in both the SNc and the SNr. (Pictures representative of a n = 3 experiment; scale bars: 0.5 mm; blue: DAPI). (BB″, CC″, DD″, EE″) Representative pictures of double immunofluorescence of IL-13 (green) with Iba-1, GFAP, NeuN, and TH (red), respectively, in control condition, 8 h of RS, and 16 weeks of RS. Arrows: co-localization of IL-13 and the specific cell type marker; arrowheads: IL-13 signal without co-localization with the cell type marker. IL-13 co-localizes (arrows) with microglia (Iba-1, Fig. BB″), neurons (NeuN, Fig. DD″), and dopaminergic cells (TH, Fig. EE″). No co-staining was found in astrocytes (GFAP, Fig. CC″). (scale bar: 200 μm in AA″, 50 μm in BE″; blue: DAPI)

In the substantia nigra IL-13 is produced by microglia and neurons

The source of IL-13 in the SN after acute and long-term RS exposure was determined by dual immunohistochemistry staining as well as by a combination of in situ hybridization/immunohistochemistry (Fig. 3 and Additional file 1: Figure S1C–C′′). Double immunofluorescence was performed for IL-13 and one of the following: the microglial marker Iba-1, the astrocytic marker GFAP, the pan-neuronal marker NeuN, or the catecholaminergic neuronal marker tyrosine hydroxylase (TH). IL-13 was expressed in the SNr and in part of the SNc (Fig. 3a) and co-localized with Iba1 as well as with NeuN (Fig. 3B–B′′, D–D′′) but not with GFAP (Fig. 3C–C′′). IL-13 was also found in a fraction of the TH-positive neurons in the SNc (Fig. 3E′–E′′). Following acute RS, microglia accounted for approximately 77% (4123 ± 204 Iba-1-positive cells out of 6450 ± 444 IL-13-positive cells) of the IL-13-positive cells. NeuN- and TH-positive cells accounted for 14 and 7%, respectively, of the remaining IL-13-positive cells. Similar values were detected after chronic stress exposure (Iba-1: 82%, NeuN: 13%, and TH: 4%), (see Additional file 1: Fig. S1B). Neuronal expression of IL-13 was also confirmed by double in situ hybridization/immunofluorescence for IL-13 mRNA and NeuN, respectively (see Additional file 1: Figure S1C–C″).

Oxidative stress and microglia activation during restraint stress are similar in Il13ra1 Y/− and Il13ra1 Y/+ mice

Activation of IL-13Rα1 contributes to neurotoxicity by increasing cellular susceptibility to oxidative stress [26]. We measured 3-Nitrotyrosine (3-NT) as an index of oxidation (Fig. 4a, b). We found that 3-NT levels were similar in both Il13ra1 Y/− and Il13ra1 Y/+ non-stressed mice (9.42 ± 0.86 a.u. vs. 10.22 ± 0.23 a.u., n = 4, NS) and were increased similarly and significantly (p < 0.001) and in both groups following 8 h of RS (21.23 ± 2.24 a.u. vs. 19.89 ± 1.36 a.u.; n = 4–6, NS). At 16 weeks of RS, 3-NT levels across genotypes were still significantly higher than in non-stressed animals used as controls but did not differ statistically in Il13ra1 Y/− compared to Il13ra1 Y/+ mice (16.86 ± 2.18 a.u. vs. 20.52 ± 2.91 a.u., p = 0.8). 3-NT levels at 20 weeks, 4 weeks after termination of stress, were similar to those of non-stressed controls animals and were not statistically different across genotypes (10.29 ± 2.18 a.u. vs. 10.43 ± 0.14 a.u., n = 4, NS). These data indicate that RS increases oxidative stress similarly in both genotypes demonstrating that ROS required for IL-13 toxicity were equally present in Il13ra1 Y/− and Il13ra1 Y/+ mice.
Fig. 4

IL-13Rα1 does not alter restraint stress-associated neuroinflammation. a Representative images showing immunofluorescence of 3-Nitrotyrosine (3-NT, green) in the SN under resting conditions and at different paradigms of RS in IL-13Rα1 wild-type and knock-out animals. Levels of oxidative damage were increased during restraint stress with no difference between genotypes. b Histograms showing the average levels of fluorescence intensity (in a.u.) of 3-Nitrotyrosine fluorescence in the SN. c Representative pictures of microglial marker Iba-1 under resting conditions and at different paradigms of RS in IL-13Rα1 wild-type and knock-out animals. Levels of oxidative were increased during restraint stress with no difference between genotypes. d Histograms showing the average levels of O.D.s (in a.u.) of Iba-1 in the SN (*p < 0.05, ***p < 0.001 compared to control condition, n = 4–6; scale bars: 100 μm in A, 200 μm in C)

Evaluation of the microglial marker Iba-1 at the same time points in Il13ra1 Y/− and Il13ra1 Y/+ mice showed that RS increase microglia activation similarly in knock-out and wild-type animals (Fig. 4c, d). Iba-1 immunoreactivity was significantly increased in for Il13ra1 Y/− mice and their wild-littermates after acute and chronic RS (p < 0.05 at 8 h and 16 weeks for Il13ra1 Y/− , p < 0.05 at 8 h, and p < 0.001 at 16 weeks for Il13ra1 Y/+ ) and was lowered after 4 weeks of non-stressed condition (NS all groups). No statistical difference was detected at any time point between genotypes. These data confirm previous finding that RS induce neuroinflammation in the SN of wild-type animals and indicate that Il13ra1 Y/− mice present the same level of microglial activation response after RS.

Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress

We next evaluated whether RS affected similarly or differently the number of DA neurons in Il13ra1 Y/− and Il13ra1 Y/+ mice (Fig. 5a, b). Non-stressed Il13ra1 Y/− and Il13ra1 Y/+ mice had similar numbers of TH-positive neurons in the SNc (9405 ± 231 for Il13ra1 Y/+ mice vs. 9240 ± 127 for Il13ra1 Y/− mice, n = 4, NS), and these numbers were found to be similar following a single acute RS session (9556 ± 113 for Il13ra1 Y/+ mice vs. 9346 ± 176 for Il13ra1 Y/− mice, n = 4, NS when compared to non-stressed control). Chronic RS reduced the number of TH-positive neurons in both wild-type Il13ra1 Y/+ (9405 ± 231 for control vs. 4180 ± 1001 for RS mice at 16 weeks, n = 4, p < 0.0001) and Il13ra1 Y/− mice, (9240 ± 127 for control vs. 6490 ± 404 for RS mice, n = 4, p < 0.01). However, Il13ra1 Y/− mice retained a significantly larger number of neurons than their wild-type littermates did (6490 ± 404 vs. 4180 ± 1001 for RS mice, n = 4, p < 0.05) indicating that Il13ra1 Y/− mice are partially protected from the loss of DA neurons during chronic RS.
Fig. 5

IL-13Rα1 contributes to dopaminergic neuronal loss during chronic stress. a Representative images of labeling of TH+ neurons using wild-type Il13ra Y/+ and knock-out Il13ra Y/− mouse brains from control mice and at different time points in the RS paradigm. b Histograms showing the number of TH+ neurons in the Il13ra Y/+ and Il13ra Y/− in the SNc under control conditions, RS 8 h, after 16 weeks of RS, and after 16 weeks of RS plus 4 weeks of rest. c Representative images of cresyl violet labeling (Nissl staining) cells used in adjacent section to the ones assessed by TH staining. d Histograms showing the average cell count of CV+ cells in the Il13ra Y/+ and Il13ra Y/− in the SNc under control conditions, RS 8 h, after 16 weeks of RS, and after 16 weeks of RS plus 4 weeks of rest. (*p < 0.05, ***p < 0.001 compared to control condition, n = 4–6; scale bars: 200 μm in A, C)

Measurements were also carried out on groups of animals that underwent the same stress paradigm but were analyzed following 4 weeks of rest after the 16 weeks of RS to evaluate whether the stress-dependent reduction in the number of TH-immunopositive cells would halt or continue. Data from these groups showed that the number of TH-positive neurons in the Il13ra1 Y/+ mice remained comparable to that observed at 16 weeks while the number of TH-positive neurons in the Il13ra1 Y/− mice further decreased to reach a value similar to that in the Il13ra1 Y/+ mice (4647 ± 144 for Il13ra1 Y/+ mice vs. 5335 ± 239 for Il13ra1 Y/− , n = 4, NS). These data indicate that lack of IL-13Rα1 did not halt but rather delayed neuronal loss during RS. To ensure that the observed loss of TH immunoreactivity reflected cellular death rather than downregulation of TH expression, cell numbers were evaluated using cresyl violet staining on adjacent sections (Fig. 5c, d). We confirmed that the reduction of cells in the SN develops during chronic restraint stress in wild-type animals (p < 0.05 at 16 weeks and 16 weeks + rest compared to control) and is delayed in Il13ra1 Y/− mice (p < 0.05 at 16 weeks compared to Il13ra1 Y/+ animals) but not completely halted where a statistical significant reduction was also found (p < 0.05 at 16 weeks + rest compared to control).

Discussion

In this study, we tested the hypothesis that IL-13Rα1 is involved in the loss of DA neurons that is observed in a mouse model of severe chronic stress where animals are exposed to daily 8 h session of restraints stress for 5 consecutive days per week to a total of 16 weeks [11].

IL-13Rα1 is expressed on DA neurons of the SNc, and its activation was previously shown to increase the susceptibility of these cells to oxidative stress [26]. We found that the daily RS session elevated IL-13 in the substantia nigra, stimulated microglia activation, and elevated oxidative stress which is necessary for IL-13-mediated toxicity. We also collected evidence that IL-13 is produced in both the pars compacta (SNc) and the pars reticularis (SNr) regions of the substantia nigra, and that cellular sources comprises microglia and neurons, including a fraction of TH-positive ones. Neuronal expression of IL-13 was previously reported in the hippocampus and the cortex following an experimental ischemic insult [31, 32], and recent studies suggested a role of this cytokine in cognitive functions [33]. Our findings showed that stress can regulate IL-13 production locally and suggest the intriguing possibility that it may act in a paracrine or, in the case of TH neuron, possibly even in an autocrine fashion. We previously demonstrated that activation of IL-13Rα1 alone did not damage DA neurons indicating that the IL-13/IL-13Rα1 system is important for the physiology of dopaminergic cells [26]. Indeed, IL-13 was found to be toxic to dopaminergic cells of the SNc only in the presence of mild oxidative stress and, until now, only in experimental paradigms employing chronic prolonged insult like regular intermittent exposure to LPS for 6 months [26].

These features make the IL-13/IL-13Rα1 a particularly attractive subject of investigation in the etiology of PD, a neurodegenerative disease believed to develop and progress over a long period of time. For the same reason, we hypothesized that IL-13/IL-13Rα1 could have a role in the loss of dopaminergic neurons suggested to occur during chronic stress [7, 9, 1113, 15, 3439].

We previously showed the RS paradigm employed here (which is particularly severe and longer compared to other studies [4043]) led to a 61% reduction in TH-positive neurons by 16 weeks of treatment [11], a finding recently replicated by an independent group using a similar paradigm [14]. Here, we further confirm the deleterious effects of chronic stress on DA neurons of the SNc as Il13ra1 Y/+ mice lost 56% of DA neurons in the SNc. We also found that mice lacking a functional IL-13Rα1 lost only 30% of cell. This, together with the evidence that the endogenous IL-13Rα1 ligand IL-13 level in the SN is elevated by restraint stress, suggests that IL-13 and IL-13Rα1 play a role in mediating the damaging effects of chronic stress on DA neurons. Stress induced oxidative damage and microglia activation, two possible mediators of neuronal damage, were affected similarly in Il13ra1 Y/− and Il13ra1 Y/+ mice indicating that IL-13Rα1 did not alter these parameters. Therefore, it seems reasonable to conclude that one of the mechanisms accounting for the reduction in dopaminergic cell loss in the Il13ra1 Y/− mice include the lack of the synergistic action between neuronal IL-13Rα1 and oxidative stress that was previously shown to exert toxicity in DA cell line [26].

In this study, we also addressed whether the damaging effects of chronic stress on dopaminergic neurons of the SNc continued upon termination of stress or not. We found that 4 weeks after stress was terminated, and the number of TH-positive neurons was similar to those measured at the termination of stress in Il13ra1 Y/+ but further decreased in Il13ra1 Y/− to a number that was still higher but not statistically significant than that of wild-type mice. This indicates that the lack of IL-13Rα1 did not halt but rather delayed neuronal loss. The mechanisms accounting for such phenomenon remain to be determined. One possibility is that activation of IL-13Rα1 is only one of the factors contributing to the stress-dependent loss of these neurons. Another is that the stress paradigm utilized was so severe that the free radical damage caused develops over time to a level that is sufficiently large to damage even neurons lacking IL-13Rα1 overriding the neurotoxicity that is observed when both IL-13 and sub-lethal doses of reactive oxygen species are present. The use of stress as an experimental paradigm to investigate loss of DA neurons is at its infancy and it will be important to investigate the effects of shorter or milder stressors.

Conclusions

We confirmed that severe chronic restraint stress can reduce the number of DA neurons and that the IL-13/IL-13Rα1 system is one, albeit not the only factor, contributing to these effects. We also showed that restraint stress might act as trigger of central production of IL-13. Blocking IL-13 or IL-13Rα1 may contribute to delay damage to DA neurons occurring during chronic severe stress.

Abbreviations

3-NT: 

3-Nitrotyrosine

CNS: 

Central nervous system

DA: 

Dopaminergic

IL-13: 

Interleukin-13

IL-13Rα1: 

Interleukin-13 receptor alpha 1

LPS: 

Lipopolysaccharide

LSCM: 

Laser scanning confocal microscope

MPTP: 

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

PD: 

Parkinson’s disease

ROS: 

Reactive oxygen species

RS: 

Restraint stress

SN: 

Substantia nigra

SNc: 

Substantia nigra pars compacta

TH: 

Tyrosine hydroxylase

Declarations

Acknowledgements

The authors thank Shyam Srinivasan, Ph.D. (Salk Institute), William Kiosses, Ph.D. (TSRI), and Kathy Spencer, Ph.D. (TSRI) for their support and assistance in stereology methods and confocal microscopy.

Funding

Funding Supported by the NIH (NS085155), The Michael J. Fox Foundation, the College of Physician and Surgeons of Ancona, Italy and The Luxembourg National Research Fund INTER/MOBILITY/2015/10533315/IMMUNPARK.

Availability of data and materials

All data generated or analyzed during this study are included in this published article. Supplementary information files are available from the corresponding author on reasonable request.

Authors’ contributions

SM, SS, YK, and BC conceived the project and wrote the paper. SM, SS, WN, TM, MGS, MS-A, and RC-C performed the experiments. SM, SS, YK, and BC analyzed and interpreted the data. GM and PM contributed in the review process and finalization of the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval

Mouse husbandry and procedures were performed under the guidelines and protocols of the Institutional Animal Care Use Committee (IACUC), the Division of Animals Resources (DAR) of The Scripps Research Institute and by the Institutional Animal Care and Use Committee of Nippon Medical School and the National Institute of Health Guide for the Care and Use of Laboratory Animals (Japan).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Molecular Medicine, The Scripps Research Institute
(2)
Department of Physiology, Nippon Medical School
(3)
Department of Infection and Immunity, Luxembourg Institute of Health
(4)
Department of Neuroscience, The Scripps Research Institute
(5)
Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche
(6)
Cellular Neurobiology Laboratory, Salk Institute for Biological Studies
(7)
Dorris Neuroscience Center, The Scripps Research Institute

References

  1. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.View ArticlePubMedGoogle Scholar
  2. Davie CA. A review of Parkinson’s disease. Br Med Bull. 2008;86:109–27.View ArticlePubMedGoogle Scholar
  3. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress. 1996;1:1–19.View ArticlePubMedGoogle Scholar
  4. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 1990;10:2897–902.PubMedGoogle Scholar
  5. Sanchez-Alavez M, Conti B, Moroncini G, Criado JR. Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. Brain Res. 2007;1158:71–80.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Gibberd FB, Simmonds JP. Neurological disease in ex-far-east prisoners of war. Lancet. 1980;2:135–7.View ArticlePubMedGoogle Scholar
  7. Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson’s disease. Exp Neurol. 2012;233:79–86.View ArticlePubMedGoogle Scholar
  8. Smith AD, Castro SL, Zigmond MJ. Stress-induced Parkinson’s disease: a working hypothesis. Physiol Behav. 2002;77:527–31.View ArticlePubMedGoogle Scholar
  9. Smith LK, Jadavji NM, Colwell KL, Katrina Perehudoff S, Metz GA. Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson’s disease. Eur J Neurosci. 2008;27:2133–46.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Sugama S, Kakinuma Y. Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: possible pathogenetic loci for depression involved in Parkinson’s disease. Neurosci Res. 2016;111:48–55.View ArticlePubMedGoogle Scholar
  11. Sugama S, Sekiyama K, Kodama T, Takamatsu Y, Takenouchi T, Hashimoto M, Bruno C, Kakinuma Y. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson’s disease. Brain Behav Immun. 2016;51:39–46.View ArticlePubMedGoogle Scholar
  12. Hemmerle AM, Dickerson JW, Herman JP, Seroogy KB. Stress exacerbates experimental Parkinson’s disease. Mol Psychiatry. 2014;19:638–40.View ArticlePubMedGoogle Scholar
  13. de Pablos RM, Herrera AJ, Espinosa-Oliva AM, Sarmiento M, Munoz MF, Machado A, Venero JL. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J Neuroinflammation. 2014;11:34.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Ong LK, Zhao Z, Kluge M, Tebay C, Zalewska K, Dickson PW, Johnson SJ, Nilsson M, Walker FR. Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe? Brain Behav Immun. 2017;60:117–25.View ArticlePubMedGoogle Scholar
  15. Sugama S, Fujita M, Hashimoto M, Conti B. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience. 2007;146:1388–99.View ArticlePubMedGoogle Scholar
  16. Hinwood M, Morandini J, Day TA, Walker FR. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex. 2012;22:1442–54.View ArticlePubMedGoogle Scholar
  17. Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, Pow DV, Day TA, Walker FR. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun. 2010;24:1058–68.View ArticlePubMedGoogle Scholar
  18. Sugama S, Takenouchi T, Fujita M, Conti B, Hashimoto M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol. 2009;207:24–31.Google Scholar
  19. Diz-Chaves Y, Pernia O, Carrero P, Garcia-Segura LM. Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J Neuroinflammation. 2012;9:71.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Kojo A, Yamada K, Kubo KY, Yamashita A, Yamamoto T. Occlusal disharmony in mice transiently activates microglia in hippocampal CA1 region but not in dentate gyrus. Tohoku J Exp Med. 2010;221:237–43.View ArticlePubMedGoogle Scholar
  21. Sugama S, Takenouchi T, Fujita M, Kitani H, Hashimoto M. Cold stress induced morphological microglial activation and increased IL-1beta expression in astroglial cells in rat brain. J Neuroimmunol. 2011;233:29–36.View ArticlePubMedGoogle Scholar
  22. Mcgeer PL, Itagaki S, Akiyama H, Mcgeer EG. Rate of cell death in Parkinsonism indicates active neuropathological process. Ann Neurol. 1988;24:574–6.View ArticlePubMedGoogle Scholar
  23. Perez Nievas BG, Hammerschmidt T, Kummer MP, Terwel D, Leza JC, Heneka MT. Restraint stress increases neuroinflammation independently of amyloid beta levels in amyloid precursor protein/PS1 transgenic mice. J Neurochem. 2011;116:43–52.View ArticlePubMedGoogle Scholar
  24. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918–34.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37:510–8.View ArticlePubMedGoogle Scholar
  26. Morrison BE, Marcondes MC, Nomura DK, Sanchez-Alavez M, Sanchez-Gonzalez A, Saar I, Kim KS, Bartfai T, Maher P, Sugama S, Conti B. Cutting edge: IL-13ralpha1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide. J Immunol. 2012;189:5498–502.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Mori S, Maher P, Conti B. Neuroimmunology of the interleukins 13 and 4. Brain Sci. 2016;6(2):18.View ArticlePubMed CentralGoogle Scholar
  28. Ramalingam TR, Pesce JT, Sheikh F, Cheever AW, Mentink-Kane MM, Wilson MS, Stevens S, Valenzuela DM, Murphy AJ, Yancopoulos GD, et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol. 2008;9:25–33.View ArticlePubMedGoogle Scholar
  29. Volpe BT, Blau AD, Wessel TC, Saji M. Delayed histopathological neuronal damage in the substantia nigra compacta (nucleus A9) after transient forebrain ischaemia. Neurobiol Dis. 1995;2:119–27.View ArticlePubMedGoogle Scholar
  30. Volpe BT, Wildmann J, Altar CA. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience. 1998;83:741–8.View ArticlePubMedGoogle Scholar
  31. Yu JT, Lee CH, Yoo KY, Choi JH, Li H, Park OK, Yan B, Hwang IK, Kwon YG, Kim YM, Won MH. Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J Neurol Sci. 2010;296:69–78.View ArticlePubMedGoogle Scholar
  32. Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J. Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci. 2015;35:11281–91.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Brombacher TM, Nono JK, De Gouveia KS, Makena N, Darby M, Womersley J, Tamgue O, Brombacher F. IL-13-mediated regulation of learning and memory. J Immunol. 2017;198(7):2681–8.PubMedGoogle Scholar
  34. Fontella FU, Cimarosti H, Crema LM, Thomazi AP, Leite MC, Salbego C, Goncalves CA, Wofchuk S, Dalmaz C, Netto CA. Acute and repeated restraint stress influences cellular damage in rat hippocampal slices exposed to oxygen and glucose deprivation. Brain Res Bull. 2005;65:443–50.View ArticlePubMedGoogle Scholar
  35. Fontella FU, Siqueira IR, Vasconcellos AP, Tabajara AS, Netto CA, Dalmaz C. Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochem Res. 2005;30:105–11.View ArticlePubMedGoogle Scholar
  36. Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O, Baratta MV, Maier SF, Yirmiya R. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry. 2014;19:699–709.View ArticlePubMedGoogle Scholar
  37. Bollinger JL, Bergeon Burns CM, Wellman CL. Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex. Brain Behav Immun. 2016;52:88–97.View ArticlePubMedGoogle Scholar
  38. Rasheed N, Ahmad A, Pandey CP, Chaturvedi RK, Lohani M, Palit G. Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochem Res. 2010;35:22–32.View ArticlePubMedGoogle Scholar
  39. Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Chui DH, Tabira T. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J Neurosci. 2000;20:1568–74.PubMedGoogle Scholar
  40. Watanabe Y, Gould E, McEwen BS. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 1992;588:341–5.View ArticlePubMedGoogle Scholar
  41. Monteiro S, Roque S, de Sa-Calcada D, Sousa N, Correia-Neves M, Cerqueira JJ. An efficient chronic unpredictable stress protocol to induce stress-related responses in C57BL/6 mice. Front Psych. 2015;6:6.Google Scholar
  42. Bardin L, Malfetes N, Newman-Tancredi A, Depoortere R. Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: relevance to human stress-associated painful pathologies. Behav Brain Res. 2009;205:360–6.View ArticlePubMedGoogle Scholar
  43. Voorhees JL, Tarr AJ, Wohleb ES, Godbout JP, Mo X, Sheridan JF, Eubank TD, Marsh CB. Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10. Plos One. 2013;8:e58488.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Conti B, Sanchez-Alavez M, Winsky-Sommerer R, Morale MC, Lucero J, Brownell S, Fabre V, Huitron-Resendiz S, Henriksen S, Zorrilla EP, et al. Transgenic mice with a reduced core body temperature have an increased life span. Science. 2006;314:825–8.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement